GB1227830A - - Google Patents
Info
- Publication number
- GB1227830A GB1227830A GB3438268A GB1227830DA GB1227830A GB 1227830 A GB1227830 A GB 1227830A GB 3438268 A GB3438268 A GB 3438268A GB 1227830D A GB1227830D A GB 1227830DA GB 1227830 A GB1227830 A GB 1227830A
- Authority
- GB
- United Kingdom
- Prior art keywords
- sulphate
- polysaccharide
- july
- suitably
- salts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229910021653 sulphate ion Inorganic materials 0.000 abstract 5
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 abstract 4
- 241000157855 Cinchona Species 0.000 abstract 3
- 229930013930 alkaloid Natural products 0.000 abstract 3
- 229920001282 polysaccharide Polymers 0.000 abstract 3
- 239000005017 polysaccharide Substances 0.000 abstract 3
- -1 polysaccharide sulphates Chemical class 0.000 abstract 3
- 235000021513 Cinchona Nutrition 0.000 abstract 2
- LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 abstract 2
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 abstract 2
- LOUPRKONTZGTKE-LHHVKLHASA-N quinidine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@H]2[C@@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-LHHVKLHASA-N 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- LJOQGZACKSYWCH-LHHVKLHASA-N (s)-[(2r,4s,5r)-5-ethyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol Chemical compound C1=C(OC)C=C2C([C@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4CC)=CC=NC2=C1 LJOQGZACKSYWCH-LHHVKLHASA-N 0.000 abstract 1
- PIIQLZXRLGJEKE-LSDHHAIUSA-N 3-[(3r,4r)-3-ethenylpiperidin-4-yl]-1-quinolin-4-ylpropan-1-one Chemical compound C=C[C@H]1CNCC[C@H]1CCC(=O)C1=CC=NC2=CC=CC=C12 PIIQLZXRLGJEKE-LSDHHAIUSA-N 0.000 abstract 1
- 235000001258 Cinchona calisaya Nutrition 0.000 abstract 1
- PIIQLZXRLGJEKE-UHFFFAOYSA-N Cinchonicine Natural products C=CC1CNCCC1CCC(=O)C1=CC=NC2=CC=CC=C12 PIIQLZXRLGJEKE-UHFFFAOYSA-N 0.000 abstract 1
- 229920002307 Dextran Polymers 0.000 abstract 1
- LJOQGZACKSYWCH-AFHBHXEDSA-N Hydroquinidine Natural products C1=C(OC)C=C2C([C@@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4CC)=CC=NC2=C1 LJOQGZACKSYWCH-AFHBHXEDSA-N 0.000 abstract 1
- 150000003797 alkaloid derivatives Chemical class 0.000 abstract 1
- DKRSEIPLAZTSFD-UHFFFAOYSA-N d-quinotoxine Natural products C12=CC(OC)=CC=C2N=CC=C1C(=O)CCC1CCNCC1C=C DKRSEIPLAZTSFD-UHFFFAOYSA-N 0.000 abstract 1
- 229960000811 hydroquinidine Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 229960001404 quinidine Drugs 0.000 abstract 1
- 229960000948 quinine Drugs 0.000 abstract 1
- DKRSEIPLAZTSFD-LSDHHAIUSA-N viquidil Chemical compound C12=CC(OC)=CC=C2N=CC=C1C(=O)CC[C@@H]1CCNC[C@@H]1C=C DKRSEIPLAZTSFD-LSDHHAIUSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
- C07D453/04—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems having a quinolyl-4, a substituted quinolyl-4 or a alkylenedioxy-quinolyl-4 radical linked through only one carbon atom, attached in position 2, e.g. quinine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB3438268 | 1968-07-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1227830A true GB1227830A (enrdf_load_stackoverflow) | 1971-04-07 |
Family
ID=10364956
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB3438268A Expired GB1227830A (enrdf_load_stackoverflow) | 1968-07-18 | 1968-07-18 |
Country Status (8)
| Country | Link |
|---|---|
| BE (1) | BE735129A (enrdf_load_stackoverflow) |
| CH (1) | CH502386A (enrdf_load_stackoverflow) |
| DE (1) | DE1936723C2 (enrdf_load_stackoverflow) |
| ES (1) | ES369337A1 (enrdf_load_stackoverflow) |
| FR (1) | FR2013170A1 (enrdf_load_stackoverflow) |
| GB (1) | GB1227830A (enrdf_load_stackoverflow) |
| NL (1) | NL149808B (enrdf_load_stackoverflow) |
| OA (1) | OA03630A (enrdf_load_stackoverflow) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995034571A3 (en) * | 1994-06-10 | 1996-05-02 | Dumex Ltd As | Drug salts |
| US6077822A (en) * | 1993-09-14 | 2000-06-20 | Dumex-Alpharma A/S | Drug salts |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1294538A (en) * | 1970-04-30 | 1972-11-01 | Rech S Et D Applic Scient Soge | Pharmaceutical compositions |
| FR2201898A1 (en) * | 1973-05-30 | 1974-05-03 | Sogeras | Vincamine arabogalactan sulphate - with prolonged activity for treating cerebrovascular disorders |
| DE69422496T2 (de) * | 1993-09-20 | 2002-07-11 | Ajinomoto Co., Inc. | Mittel gegen malaria |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1143204B (de) * | 1958-08-05 | 1963-02-07 | Mundipharma Ag | Verfahren zur Herstellung von Chinidingalacturonat und Chinidinpolygalacturonat |
| DE1218457B (de) * | 1961-10-10 | 1966-06-08 | Mundipharma Ag | Verfahren zur Herstellung von Dihydrochinidingalakturonat und Dihydrochinidinpolygalakturonat |
-
1968
- 1968-07-18 GB GB3438268A patent/GB1227830A/en not_active Expired
-
1969
- 1969-06-25 BE BE735129D patent/BE735129A/xx not_active IP Right Cessation
- 1969-06-26 CH CH994669A patent/CH502386A/fr not_active IP Right Cessation
- 1969-07-09 ES ES369337A patent/ES369337A1/es not_active Expired
- 1969-07-10 FR FR6923466A patent/FR2013170A1/fr active Pending
- 1969-07-17 NL NL696910987A patent/NL149808B/xx not_active IP Right Cessation
- 1969-07-18 OA OA53676A patent/OA03630A/xx unknown
- 1969-07-18 DE DE1936723A patent/DE1936723C2/de not_active Expired
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6077822A (en) * | 1993-09-14 | 2000-06-20 | Dumex-Alpharma A/S | Drug salts |
| WO1995034571A3 (en) * | 1994-06-10 | 1996-05-02 | Dumex Ltd As | Drug salts |
Also Published As
| Publication number | Publication date |
|---|---|
| BE735129A (enrdf_load_stackoverflow) | 1969-12-01 |
| OA03630A (fr) | 1971-12-24 |
| ES369337A1 (es) | 1971-06-01 |
| NL149808B (nl) | 1976-06-15 |
| NL6910987A (enrdf_load_stackoverflow) | 1970-01-20 |
| FR2013170A1 (enrdf_load_stackoverflow) | 1970-03-27 |
| CH502386A (fr) | 1971-01-31 |
| DE1936723C2 (de) | 1983-12-22 |
| DE1936723A1 (de) | 1970-05-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BE807223A (fr) | Conteneur d'expedition et de distributions | |
| BE793408A (fr) | Dispositif d'emmagasinage, de classement et de distribution d'articles | |
| CA960803A (en) | Child's article of furniture | |
| GB1247976A (en) | Pharmaceutical compositions, amino acid ester compounds, and methods for their production | |
| GB1227830A (enrdf_load_stackoverflow) | ||
| AU468490B2 (en) | Furylmethyl morphinane derivatives and pharmaceutical compositions containing them | |
| CA928290A (en) | 5'-0-ester of ara-cytidine and their preparation | |
| FR2288982A1 (fr) | Methode et necessaire de dosage par saturation de l'acide folique et de ses composes | |
| CA924128A (en) | Cobalt-chromium base alloy and articles produced therefrom | |
| GB1358001A (en) | Pharmaceutical compositions | |
| GB1435685A (en) | Hydroxyl-subst | |
| GB1321419A (en) | Pharmaceutical composition | |
| GB1245316A (en) | Novel quinazolinone derivative and process for production thereof | |
| GB1440850A (en) | Vaso-regulator compositions | |
| GB1402085A (en) | 15-hydroxy vincamine | |
| GB1391918A (en) | Iodohydroxyphenyl-aminoalkane derivatives and process for their manufacture | |
| BE760464A (fr) | L'acide 4-bromo-3-hydroxy-hippurique, sa preparation et son utilisationen medecine comme inhibiteur de l'histamine | |
| GB1395898A (en) | Dihydroquinidine derivative | |
| CA927076A (en) | Process for the manufacture of fine particulate maddrell's salt | |
| CA815054A (en) | Salts of n-carbamyl-glutamic acid and of n-carbamyl-aspartic acid | |
| AU415415B2 (en) | Cinchona alkaloid salts and compositions containing them | |
| GB1249907A (en) | Process for the sulphonation of a glycopeptide | |
| GB1469208A (en) | Diphenylpyraline salt | |
| CA804454A (en) | Methods of producing reflecting markers and the resulting marker | |
| GB1254125A (en) | Pharmaceutical composition suitable for the treatment of certain vascular diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed | ||
| PE20 | Patent expired after termination of 20 years |